Dr. Lottich is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8040 Clearvista Pkwy
Ste 290
Indianapolis, IN 46256Phone+1 317-621-7780Fax+1 317-621-7783
Education & Training
Duke University HospitalResidency, Surgery, 1981 - 1989
Duke University School of MedicineClass of 1981
Certifications & Licensure
IN State Medical License 1989 - 2025
NC State Medical License 1983 - 2001- American Board of Surgery Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Indianapolis Monthly Castle Connolly, 2011, 2013
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- 28 citationsTARGIT-R (Retrospective): 5-Year Follow-Up Evaluation of Intraoperative Radiation Therapy (IORT) for Breast Cancer Performed in North America.Stephanie A. Valente, Rahul D. Tendulkar, Sheen Cherian, Chirag Shah, Darrel L. Ross
Annals of Surgical Oncology. 2021-01-12 - 36 citationsTARGIT-R (Retrospective): North American Experience with Intraoperative Radiation Using Low-Kilovoltage X-Rays for Breast CancerStephanie A. Valente, Rahul D. Tendulkar, Sheen Cherian, Colin O'Rourke, Jon M. Greif
Annals of Surgical Oncology. 2016-05-09 - 93 citationsThe diagnostic distinction between malignant mesothelioma of the pleura and adenocarcinoma of the lung as defined by a monoclonal antibody (B72.3)Cheryl A. Szpak, William W. Johnston, Victor L. Roggli, J Kolbeck, S C Lottich
The American Journal of Pathology. 1986-02-01
Grant Support
- Monoclonal Antibodies To Carcinoma AntigensNational Cancer Institute1985
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
